The outcomes of prospective studies indicate that, in patients with non-valvular AF, high vWF plasma concentrations, in conjunction with established cardiovascular risk factors, might more accurately predict clinical outcomes, such as stroke or all-cause death. This evidence concerns the gene VWF and Stroke.